
Hura Imaging is a medical imaging software company specializing in AI innovations for imaging-guided treatment. Their mission is to enhance the safety, efficiency, and quality of medical imaging processes, particularly for image-guided treatment. They offer FDA-cleared solutions like HuraCTP® for CT perfusion denoising, HuraASL® (CereFlow) for arterial spin labeling MRI, and HuraRT® (DV.Target) for deep learning-based organ contouring. These technologies aim to improve diagnostic accuracy, reduce costs, and increase regulatory compliance in medical imaging. The company was founded in 2016 and has received funding from the NIH STTR/SBIR program, with key team members having extensive experience in medical imaging, AI, and business development. They collaborate with institutions like USC and have achieved FDA clearance for their flagship products.

Hura Imaging is a medical imaging software company specializing in AI innovations for imaging-guided treatment. Their mission is to enhance the safety, efficiency, and quality of medical imaging processes, particularly for image-guided treatment. They offer FDA-cleared solutions like HuraCTP® for CT perfusion denoising, HuraASL® (CereFlow) for arterial spin labeling MRI, and HuraRT® (DV.Target) for deep learning-based organ contouring. These technologies aim to improve diagnostic accuracy, reduce costs, and increase regulatory compliance in medical imaging. The company was founded in 2016 and has received funding from the NIH STTR/SBIR program, with key team members having extensive experience in medical imaging, AI, and business development. They collaborate with institutions like USC and have achieved FDA clearance for their flagship products.
What they do: Medical imaging software company developing FDA-cleared AI and physics-based products for perfusion CT/MRI and imaging-guided treatment workflows
Flagship products: HuraCTP (CT perfusion denoising), HuraASL/CereFlow (ASL perfusion MRI), HuraRT/DV.Target (organ contouring)
Founding / HQ: Founded 2016–2017; headquartered in Los Angeles, CA
Funding highlights: NIH STTR/SBIR awards (including a two-year ~$1.6M award) and angel investment
Regulatory status: FDA 510(k) clearance for HuraCTP
Perfusion imaging (CT and MRI), image denoising, automated organ contouring, and imaging-guided treatment workflow optimization
2017
Medical imaging / Healthtech
Approximately $1,600,000 (two-year award reported)
Non-dilutive grant funding reported by the company
250000.00
Company mentions angel investment support